Clinical Trials Browser

Phase 1 × Glioma × Ascorbic Acid × Clear all

NCT02833701 2023-10-24

Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma

Phase 1 Terminated

Glioblastoma, Glioma

NCT01891747 2022-03-10

A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma

Phase 1 Completed

Glioma